Antigenic and genetic characterization of serogroup C meningococci isolated from invasive meningococcal disease cases in Canada from 1999 to 2003

Canadian Journal of Microbiology

Volumn 51, Issue 7, 2005, Pages 523-530

  Law, Dennis K S ^a   Stoltz, Jan ^a   Henderson, Averil M ^a   Tsang, Raymond S W ^a  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

Antigenic; Genetic; Meningococci; Serogroup C; Variants

Indexed keywords

ANTIGENS; BIOLOGICAL MEMBRANES; CLONING; ELECTROPHORESIS; PATIENT TREATMENT; PROTEINS;

ANTIGENIC CHARACTERIZATION; MENINGOCOCCI; SEROGROUP C; VARIANTS;

DISEASE CONTROL;

OUTER MEMBRANE PROTEIN;

GENETIC ANALYSIS;

ARTICLE; BACTERIAL MEMBRANE; BACTERIAL MUTATION; BACTERIUM ISOLATE; CANADA; ENDEMIC DISEASE; EPIDEMIC; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEROTYPE; VACCINATION;

AMINO ACID SEQUENCE; ANTIGENIC VARIATION; BASE SEQUENCE; HUMANS; INCIDENCE; MENINGOCOCCAL INFECTIONS; MOLECULAR SEQUENCE DATA; NEISSERIA MENINGITIDIS, SEROGROUP C; PORINS; SEQUENCE ANALYSIS, DNA; SEROTYPING; VARIATION (GENETICS);

BACTERIA (MICROORGANISMS); NEISSERIA MENINGITIDIS;

EID: 28344452663     PISSN: 00084166     EISSN: None     Source Type: Journal    
DOI: 10.1139/w05-085     Document Type: Article

References (50)

1. Abdillahi, H., and Poolman, J.T. 1987. Whole cell ELISA for typing Neisseria meningitidis with monoclonal antibodies. FEMS Microbiol. Lett. 48: 367-371.
2. Achtman, M. 2004. (Max-Planck Institut fur Infektionsbiologie.) Personal communication.
3. Alcala, B., Arreaza, L., Salcedo, C., Uria, M.J., De La Fuente, L., and Vazquez, J.A. 2002. Capsule switching among C:2b:P1.2,5 meningococcal epidemic strains after mass immunization campaign, Spain. Emerg. Infect. Dis. 8: 1512-1514.
4. Ashton, P.E., Ryan, J.A., Jones, C., Brodeur, B.R., and Diena, B.B. 1983. Serotypes of Neisseria meningitidis associated with an increased incidence of meningitis cases in the Hamilton area, Ontario, during 1978 and 1979. Can. J. Microbiol. 29: 129-136.
5. Ashton, F.E., Ryan, J.A., Borczyk, A., Caugant, D.A., Mancino, L., and Huang, D. 1991a. Emergence of a virulent clone Neisseria meningitidis serotype 2a that is associated with meningococcal disease in Canada. J. Clin. Microbiol. 29: 2489-2493.
6. Ashton, F.E., Ryan, J.A., Poolman, J.T., Abdillahi, H., and Zollinger, W.D. 1991b. Serotypes and subtypes of Neisseria meningitidis serogroup B strains associated with meningococcal disease in Canada, 1977-1989. Can. J. Microbiol. 37: 613-617.
7. Berron, S., La Fuente, D., Martin, E., and Vazquez, J.A. 1998. Increasing incidence of meningococcal disease in Spain associated with a new variant of serogroup C. Eur. J. Clin. Microbiol. Infect. Dis. 17: 85-89.
8. Caugant, D.A. 1998. Population genetics and molecular epidemiology of Neisseria meningitidis. APMIS, 106: 505-525.
9. Caugant, D.A., Bovre, K., Gaustad, P., Bryn, K., Holten, E., Hoiby, E.A., and Froholm, L.O. 1986. Multilocus genotypes determined by enzyme electrophoresis of Neisseria meningitidis isolated from patients with systemic disease and healthy carriers. J. Gen. Microbiol. 132: 641-652.
10. Davidsen, T., Rodland, E.A., Lagesen, K., Seeberg, E., Rognes, T., and Tonjum, T. 2004. Biased distribution of DNA uptake sequences towards genome maintenance genes. Nucleic Acids Res. 32: 1051-1058.
11. Decks, S., Kertesz, D., Ryan, A., and Ashton, F. 1997. Surveillance of invasive meningococcal disease in Canada, 1995-1996. Can. Commun. Dis. Rep. 23: 121-125.
12. Derrick, J.P., Urwin, R., Suker, J., Feavers I.M., and Maiden, M.C. 1999. Structural and evolutionary inference from molecular variation in Neisseria porins. Infect. Immun. 67: 2406-2413.
13. De Wals, P., Dionne, M., Douville-Fradet, M., Bouliane, N., Drapeau, J., and De Serres, G. 1996. Impact of a mass immunization campaign against serogroup C meningococcus in the province of Quebec, Canada. Bull. W.H.O. 74: 407-411.
14. Farley, J.D., and Osei, W. 1992. Invasive meningococcal disease, British Columbia December 1991-March 1992. Can. J. Public Health, 83: 138-140.
15. Feavers, I. 2004. (National Institute for Biological Standards and Controls.) Personal communication.
16. Feavers, I.M., Heath, A.B., Bygraves, J.A., and Maiden, M.C.J. 1992. Role of horizontal genetic exchange in the antigenic variation of the class 1 outer membrane protein of Neisseria meningitidis. Mol. Microbiol 6: 489-495.
17. Frasch, C.E., Zollinger, W.D., and Poolman, J.T. 1985. Serotyping antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev. Infect. Dis. 7: 504-510.
18. Heimann, G.A., Mikel, D.E., Naus, M., Goel, V., Tischler, M., Carlson, J.A.K., Schabas, R., Pasut, G., Borczyk, A., and Krishnan, C. 1989. Meningococcal disease in Ontario during the winter of 1988-89. Can. Dis. Wkly. Rep. 15: 59-62.
19. Jelfs, J., Munro, R., Ashton, F.E., and Caugant, D.A 2000. Genetic characterization of a new variant within the ET-37 complex of Neisseria meningitidis associated with outbreaks in various parts of the world. Epidemiol. Infect. 125: 285-298.
20. Jolley, K., and Chan, M.S. 2004. Neisseria multilocus sequence typing website. the University of Oxford, Oxford, U.K. Available from http://pubmlst.org/neisseria/ [accessed on 15 January 2005].
21. Kertesz, D., Coulthart, M., Ryan, A., Johnson, W., and Ashton, F. 1998. Serogroup B electrophoresis type 15 Neisseria meningitidis in Canada. J. Infect. Dis. 177: 1754-1757.
22. Law, D.K.S., Henderson, A.M., and Tsang, R.S.W. 2004. DNA sequence analysis of the PorB protein of nonserotypeable serogroup C ET-15 meningococci suggests a potential mutational hot spot on their serotype antigens. J. Clin. Microbiol. 42: 2718-2723.
23. Maiden, M.C.J., Bygraves, J.A., Feil, E., Morelli, G., Russell, J.E., Urwin, R., Zhang, Q., Zhou, J., Zurth, K., Caugant, D.A., Feavers, I.M., Achtman, M., and Spratt, R.G. 1998. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc. Natl. Acad. Sci. U.S.A. 95: 3140-3145.
24. National Advisory Committee on Immunization. 2001. An Advisory Committee Statement: Statement on recommended use of meningococcal vaccine. Can. Commun. Dis. Rep. 27: 2-36.
25. Riou, J.Y., and Guibourdenche, M. 1992. Laboratory methods: Neisseria and Branhamella. Institut Pasteur, Paris, France.
26. Sacchi, C.T., Zanella, R.C., Caugant, D.A., Frasch, C.E, Hidalgo, N.T., Milagres, L.G., Pessoa, L.L., Ramos, S.R., Carmago, M.C.C., and Melles, C.E.A. 1992. Emergence of a new clone of serogroup C Neisseria meningitidis in Sao Paulo area, Brazil. J. Clin. Microbiol. 30: 1282-1286.
27. Sacchi, C.T., Lemos, A.P.S., Whitney, A.M., Solari, C.A., Brandt, M.E., Melles, C.E.A., Frasch, C.E., and Mayer, L.W. 1998a. Correlation between serological and sequence analysis of the PorB outer membrane protein in the Neisseria meningitidis serotyping scheme. Clin. Diagn. Lab. Immunol. 5: 348-354.
28. Sacchi, C.T., Lemos, A.P.S., Brandt, M.E., Whitney, A.M., Melles, C.E.A., Solari, C.A., Frasch, C.E., and Mayer, L.W. 1998b. Proposed standardization of Neisseria meningitidis PorA variable-region typing nomenclature. Clin. Diagn. Lab. Immunol. 5: 845-855.
29. Selander, R.K., Caugant, D.A., Ochman, H.M., Musser, J.M., Gilmour, M.N., and Whittam, T.S. 1986. Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Appl. Environ. Microbiol. 51: 873-884.
30. Smith, N.H., Maynard Smith, J., and Spratt, B.G. 1995. Sequence evolution of the porB gene of Neisseria gonorrhoeae and Neisseria meningitidis: evidence of positive Darwinian selection. Mol. Biol. Evol. 12: 363-370.
31. Smith, I., Lehmann, A.K., Lie, L., Digranes, A., Caugant, D.A., Hoiby, E.A., Froholm, L.O., and Halstensen, A. 1999. Outbreak of meningococcal disease in Western Norway due to a new serogroup C variant of the ET-5 clone: effect of vaccination and selective carriage eradication. Epidemiol. Infect. 123: 373-382.
32. Squires, S.G., Pelletier, L., Mungai, M., Tsang, R., Collins, F, and Stoltz, J. 2000. Invasive meingococcal disease disease in Canada, 1 January 1997 to 31 December 1998. Can. Commun. Dis. Rep. 26: 177-182.
33. Squires, S.G., Deeks, S.L., and Tsang, R.S.W. 2004. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January 1999, through 31 December 2001. Can. Commun. Dis. Rep. 30: 17-28.
34. Sweet, L. 1992. The Prince Edward Island meningoccal immunization program. January - February 1992. Can. J. Public Health, 83: 138-140.
35. Tolomeo, O., Buffett, C., and Richardson, E. 1998. Management of a cluster of cases of invasive group C Neisseria meningitidis infections in the Hamilton-Wentworth Region. Can. Commun. Dis. Rep. 24: 122-126.
36. Tribe, D.E., Zaia, A.M., Griffith, J.M., Robinson, P.M., Li, H.Y., Taylor, K.N., and Hogg, G.G. 2002. Increase in meningococcal disease associated with the emergence of a novel ST-Il variant of serogroup C Neisseria meningitidis in Victoria, Australia, 1999-2000. Epidemiol. Infect. 128: 7-14.
37. Tsang, R.S.W. 2004. (National Microbiology Laboratory.) Unpublished data.
38. Tsang, R.S.W., Squires, S.O., Zollinger, W.D., and Ashton, A.E. 2002. Distribution of serogroups of Neisseria meningitidis and antigenic characterization of serogroup Y meningococci in Canada, January 1, 1999 to June 30, 2001. Can. J. Infect. Dis. 13: 391-396.
39. Tsang, R.S.W., Kiefer, L., Law, D.K.S., Stoltz, J., Shahin, R., Brown, S., and Jamieson, F. 2003a. Outbreak of serogroup C meningococcal disease caused by a variant of Neisseria meningitidis serotype 2a ET-15 in a community of men who have sex with men. J. Clin. Microbiol. 41: 4411-4414.
40. Tsang, R.S.W., Squires, S.O., and Tarn, T.W.S. 2003b. Characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease cases in Canada in 2001. Can. J. Microbiol. 49: 633-638.
41. Tsang, R.S.W., Tsai, C.M., Zhu, P., Ringuette, L., Lorange, M., and Law, D.K.S. 2004. Phenotypic and genetic characterization of a unique variant of serogroup C ET-15 meningococci (with the antigenic formula of C:2a:P1.7,l) causing invasive meningococcal disease in Quebec, Canada. J. Clin. Microbiol. 42: 1460-1465.
42. Tyler, S., and Tsang, R. 2004. Genetic analysis of Canadian isolates of C:2a:P1.2,5 and B:2a:P1.2,5 Neisseria meningitidis strains belonging to the hypervirulent clone of ET-15. Can. J. Microbiol. 50: 433-43.
43. Tyrrell, G.J., Chui, L., Johnson, M., Chang, N., Rennie, R.P., and Talbot, J.A. 2002. Outbreak of Neisseria meningitidis, Edmonton, Alberta, Canada. Emerg. Infect. Dis. 8: 519-521.
44. Urwin, R., Holmes, B.C., Fox, A.J., Derrick J.P., and Maiden, M.C.J. 2002. Phylogenetic evidence for frequent positive selection and recombination in the meningococcal surface antigen PorB. Mol. Biol. Evol. 19: 1686-1694.
45. Varughese, P.V., and Acres, S. 1983. Meningococcal disease in Canada and serogroup distribution. Can. Dis. Wkly. Rep. 9: 177-180.
46. Varughese, P.V., and Carter, A.O. 1989. Meningococcal disease in Canada. Surveillance summary to 1987. Can. Dis. Wkly. Rep. 15: 89-96.
47. Vazquez, J.A., Berron, S., O'Rourke, M., Carpenter, G., Feil, E., Smith, N.H., and Spratt, R.G. 1995. Interspecies recombination in nature: a meningococcus that has acquired a gonococcal PIB porin. Mol. Microbiol. 15: 1001-1007.
48. Vogel, U., Claus, H., Frosch, M., and Caugant, D.A. 2000. Molecular basis for distinction of the ET-15 clone within the ET-37 complex of Neisseria meningitidis. J. Clin. Microbiol. 38: 941-942.
49. Wang, J.F., Caugant, D.A., Morelli, G., Koumare, B., and Achtman, M. 1993. Antigenic and epidemiologic properties of the ET-37 complex of Neisseria meningitidis. J. Infect. Dis. 167: 1320-1329.
50. Whalen, C.M., Hockin, J.C., Ryan, A., and Ashton, F. 1995. The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992. Emergence of a variant clone of Neisseria meningitidis. JAMA, 273: 390-394.